Home
>
National Drug Code (NDC)
>
Lexiscan
Lexiscan - 0469-6501-89 - (regadenoson)
Drug Information of Lexiscan
| Product NDC: | 0469-6501 |
| Proprietary Name: | Lexiscan |
| Non Proprietary Name: | regadenoson |
| Active Ingredient(s): | .08 mg/mL & nbsp; regadenoson |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lexiscan
| Product NDC: | 0469-6501 |
| Labeler Name: | Astellas Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022161 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080410 |
Package Information of Lexiscan
| Package NDC: | 0469-6501-89 |
| Package Description: | 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89) |
NDC Information of Lexiscan
| NDC Code | 0469-6501-89 |
| Proprietary Name | Lexiscan |
| Package Description | 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89) |
| Product NDC | 0469-6501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | regadenoson |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080410 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | REGADENOSON |
| Strength Number | .08 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
